ArticleThe European journal of neuroscience2026
Asymmetric Cholinergic Basal Forebrain Atrophy Marks Freezing of Gait in Parkinson's Disease.
Article in The European journal of neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Asymmetric Cholinergic Basal Forebrain Atrophy Marks Freezing of Gait in Parkinson's Disease.The European journal of neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Freezing of gait (FoG) and falls are among the most disabling symptoms in late-stage Parkinson's disease (PD). While right-lateralised thalamic cholinergic denervation has been linked to FoG and gait impairment, it is unclear whether similar asymmetry exists within the cortically-projecting cholinergic basal forebrain (cBF), particularly the nucleus basalis of Meynert (Ch4). In this cross-sectional study, we assessed structural MRI in 136 nondemented people with PD, stratified into three groups: FoG (n = 18), fallers without FoG (n = 31) and nonfallers without FoG (n = 87). Subregional cBF volumes were quantified using volumetry, normalised by total intracranial volume and compared across groups. Mixed ANOVAs revealed significantly reduced Ch4 and Ch4p volumes in the FoG group compared to both other groups, with right-lateralised Ch4p atrophy observed specifically in FoG. After adjusting for disease severity, sex, levodopa equivalent dose (LEDD), and most affected side, the FoG group continued to show significantly reduced volumes in only the right Ch4p. A mediation model indicated that global cognitive performance (MoCA) did not significantly mediate the association between Ch4p volume and FoG status, suggesting that Ch4p degeneration may contribute to FoG through mechanisms not captured by global cognition alone. Overall, the findings support a right-hemisphere cholinergic vulnerability in FoG, implicating Ch4p degeneration in networks relevant to both gait regulation and attentional-visuospatial function. Future longitudinal studies are needed to determine whether this lateralised structural vulnerability predicts progression to FoG or cognitive decline in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.